3 results
Approved WMOCompleted
The primary objective is to test the hypothesis that galcanezumab is superior to placebo in the prevention of migraine in patients with treatment-resistant migraine.The key secondary objective are:- To compare galcanezumab with placebo with respect…
Approved WMOPending
Objectives: Main objective: A personalized intervention of patients* stress and anxiety based on the combined use of standard measures (e.g. questionnaires) and advanced tools (smart watch sensors, mHealth app and VR) through a radical Artificial…
Approved WMORecruiting
The overall aim of this study is to demonstrate increase of tumor-infiltrating CD8+ T cells in non-small cell lung cancer during neo-adjuvant treatment with durvalumab (MEDI4736).